NCT04766944

Brief Summary

This single-center prospective cohort study conducted at the adult trauma ICU of the Montreal General Hospital (MGH) affiliated with the McGill University Health Centre (MUHC) aims to determine the incidence and associated risk factors of augmented renal clearance (ARC) in critically ill trauma patients of 50 years old and above.

Trial Health

30
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Mar 2024

Geographic Reach
1 country

1 active site

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 14, 2021

Completed
9 days until next milestone

First Posted

Study publicly available on registry

February 23, 2021

Completed
3 years until next milestone

Study Start

First participant enrolled

March 1, 2024

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2024

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2025

Completed
Last Updated

December 13, 2024

Status Verified

December 1, 2024

Enrollment Period

9 months

First QC Date

February 14, 2021

Last Update Submit

December 10, 2024

Conditions

Keywords

Augmented renal clearanceCritical illnessCritical careIntensive care unitTraumaPolytraumaTraumatic brain injuryElderlyMiddle-aged

Outcome Measures

Primary Outcomes (1)

  • To determine the incidence of augmented renal clearance in critically ill trauma patients aged 50 years and older

    The incidence of augmented renal clearance is dichotomic: presence or absence of augmented renal clearance defined as a creatinine clearance of ≥ 130 mL/min/m² measured by a daily 8 hour urine collection

    Once a day, up to 14 days

Secondary Outcomes (1)

  • To determine demographic and clinical risk factors for ARC in critically ill trauma patients aged 50 years and older

    Up to 14 days

Study Arms (1)

Critically ill trauma patients of 50 years old and above

Patients of 50 years old and above admitted to the Montreal General Hospital intensive care unit for trauma

Other: No intervention

Interventions

No intervention

Critically ill trauma patients of 50 years old and above

Eligibility Criteria

Age50 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients aged 50 years old or older admitted to the ICU for traumatic brain injury (TBI) and/or polytrauma between January 2021 and October 2021

You may qualify if:

  • Admission to the ICU for isolated traumatic brain injury (TBI), polytrauma without TBI or combined polytrauma and TBI
  • Expected ICU length of stay of more than 24 hours
  • Age of ≥ 50 years old at the time of admission
  • Serum creatinine ≤ 120 μmol/L at the time of admission
  • Presence of an indwelling urinary catheter
  • Consent is obtained from the patient or its surrogate decision-maker within 7 days of ICU admission

You may not qualify if:

  • History of renal replacement therapy (RRT) (intermittent dialysis or peritoneal dialysis), nephrectomy or renal transplant
  • Patient developing acute kidney injury (AKI)
  • ICU physician considered patient unsuitable for enrollment due to poor prognosis
  • Burn-related trauma
  • Patient is admitted \> 48 hours post-traumatic event

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

McGill University Health Centre

Montreal, Quebec, H4A3J1, Canada

Location

Biospecimen

Retention: SAMPLES WITHOUT DNA

Urine collected from a daily 8-hour collection via an indwelling urinary catheter will be used to assess total daily urine volume. Urine samples of 2 ml will be taken and kept in a biomedical laboratory freezer at -80°C to be analyzed in batches every 3 months.

MeSH Terms

Conditions

Critical IllnessMultiple TraumaBrain Injuries, TraumaticWounds and Injuries

Condition Hierarchy (Ancestors)

Disease AttributesPathologic ProcessesPathological Conditions, Signs and SymptomsBrain InjuriesBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesCraniocerebral TraumaTrauma, Nervous System
0

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Full clinical professor

Study Record Dates

First Submitted

February 14, 2021

First Posted

February 23, 2021

Study Start

March 1, 2024

Primary Completion

December 1, 2024

Study Completion

December 1, 2025

Last Updated

December 13, 2024

Record last verified: 2024-12

Locations